You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Refractory Advanced Biliary Cancers

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer of the Bile Duct Trial in Tampa, Chapel Hill, Richmond (Regorafenib)

Completed
Has Results
  • Cancer of the Bile Duct
  • Tampa, Florida
  • +2 more
Sep 20, 2021

Advanced Biliary Tract Cancer Trial in United States (Durvalumab, Regorafenib)

Recruiting
  • Advanced Biliary Tract Cancer
  • Overland Park, Kansas
  • +4 more
May 17, 2022

Advanced Bile Duct Carcinoma, Advanced Gallbladder Carcinoma, Refractory Bile Duct Carcinoma Trial in Rochester (Irinotecan,

Active, not recruiting
Has Results
  • Advanced Bile Duct Carcinoma
  • +17 more
  • Rochester, Minnesota
    Mayo Clinic
Jan 5, 2023

Advanced Biliary Tract Carcinoma, Advanced Colorectal Carcinoma, Advanced Gastroesophageal Junction Adenocarcinoma Trial in

Not yet recruiting
  • Advanced Biliary Tract Carcinoma
  • +32 more
  • Biospecimen Collection
  • +6 more
  • Chicago, Illinois
    Northwestern University
Feb 6, 2023

Advanced Malignant Solid Tumor, Bile Duct Carcinoma, Recurrent Malignant Solid Tumor Trial in Indianapolis, Seattle (Afatinib

Completed
  • Advanced Malignant Solid Neoplasm
  • +6 more
  • Afatinib Dimaleate
  • +2 more
  • Indianapolis, Indiana
  • +1 more
Jun 3, 2022

Biliary Tract Carcinoma, Cholangiocarcinoma, Bile Duct Cancer Trial in Madison (Gemcitabine, Cisplatin, Zimberelimab)

Not yet recruiting
  • Biliary Tract Carcinoma
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin
Sep 15, 2023

Biliary Tract Cancer Trial in Montréal (Tumour and germline molecular profiling)

Recruiting
  • Biliary Tract Cancer
  • Tumour and germline molecular profiling
  • MontrĂ©al, Quebec, Canada
    McGill University Health Centre
Nov 2, 2022

Biliary Tract Cancer Trial (GEN-001, Pembrolizumab, mFOLFOX)

Not yet recruiting
  • Biliary Tract Cancer
  • (no location specified)
Aug 16, 2023

Cholangiocarcinoma, Stage III Gallbladder Cancer AJCC v7, Stage IIIA Gallbladder Cancer AJCC v7 Trial in Scottsdale, Rochester

Active, not recruiting
Has Results
  • Cholangiocarcinoma
  • +6 more
  • Laboratory Biomarker Analysis
  • Trifluridine/Tipiracil Hydrochloride Combination Agent TAS-102
  • Scottsdale, Arizona
  • +1 more
Jan 4, 2023

Biliary Tract Cancer, Cholangiocarcinoma, Gall Bladder Cancer Trial (CTX-009, Paclitaxel)

Not yet recruiting
  • Biliary Tract Cancer
  • +3 more
  • (no location specified)
Aug 16, 2022

Biliary Tract Cancer, Cholangiocarcinoma, Biliary Tract Tumors Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL))

Recruiting
  • Biliary Tract Cancer
  • +2 more
  • Tumor Infiltrating Lymphocytes (TIL)
  • Pittsburgh, Pennsylvania
    Allyson Welsch
Jul 21, 2022

Biliary Tract Cancer Trial in Philadelphia (XmAb20717)

Recruiting
  • Biliary Tract Cancer
  • Philadelphia, Pennsylvania
    Abramson Cancer Center at University of Pennsylvania
Apr 11, 2022

Biliary Tract Tumors Trial (Envafolimab plus Gemcitabine&Cisplatin, Gemcitabine&Cisplatin)

Not yet recruiting
  • Biliary Tract Neoplasms
  • (no location specified)
Jun 8, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial in Houston (Laboratory

Completed
  • Advanced Malignant Solid Neoplasm
  • +3 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 21, 2022

Hepatocellular Carcinoma, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancers Trial (ABBV-400)

Not yet recruiting
  • Hepatocellular Carcinoma
  • +6 more
  • (no location specified)
Oct 10, 2023

Advanced Biliary Tract Cancer, Neuroendocrine Tumors, Female Reproductive System Tumor Trial in Australia (Ipilimumab,

Recruiting
  • Advanced Biliary Tract Cancer
  • +3 more
  • Albury, New South Wales, Australia
  • +11 more
Oct 31, 2022

Small Cell Lung Cancer (SCLC), Large Cell Neuroendocrine Cancer (LCNEC), Neuroendocrine Prostate Cancer (NEPC) Trial (PT217)

Not yet recruiting
  • Small Cell Lung Cancer (SCLC)
  • +3 more
  • (no location specified)
Dec 7, 2022

NHL, Multiple Myeloma, Blood Cancer Trial in Minneapolis, Houston, Fairfax (IDP-023, Rituximab, Daratumumab)

Recruiting
  • NHL
  • +6 more
  • Minneapolis, Minnesota
  • +2 more
Nov 7, 2023

Gastric Cancer in Situ, Pancreatic Cancers, Biliary Cancers Trial in Taipei (Oxaliplatin, Albumin-Bound Paclitaxel

Completed
  • Gastric Cancer in Situ
  • +2 more
  • Taipei, Taiwan
    Taiwan Cooperative Oncology Group, National Health Research Inst
Apr 5, 2022

Biliary Tract Cancer Trial in Riyadh (FOLFIRINOX)

Recruiting
  • Biliary Tract Cancer
  • FOLFIRINOX
  • Riyadh, Saudi Arabia
    king Faisal Specialist Hospital and Research Center
Aug 30, 2021

Adenocarcinoma of the Pancreas, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in Buffalo (dovitinib lactate,

Completed
  • Adenocarcinoma of the Pancreas
  • +3 more
  • dovitinib lactate
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2022

Biliary Cancer Trial in San Francisco (Pembrolizumab, Sargramostim)

Completed
Has Results
  • Biliary Cancer
  • San Francisco, California
    University of California San Francisco
Jan 21, 2022

Colon Cancer, Colorectal Cancer, Colorectal Carcinoma Trial in Tampa (Pembrolizumab, Ibrutinib)

Completed
Has Results
  • Colon Cancer
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jun 1, 2022

Cholangiocarcinoma, Liver and Intrahepatic Bile Duct Carcinoma, Stage III Gallbladder Cancer AJCC v7 Trial in Houston

Completed
  • Cholangiocarcinoma
  • +11 more
  • Laboratory Biomarker Analysis
  • Ramucirumab
  • Houston, Texas
    M D Anderson Cancer Center
Jul 7, 2022

Opioid-Related Disorders, Pain Management, Pain Management and Care Trial in Boston (Psilocybin)

Not yet recruiting
  • Opioid-Related Disorders
  • +4 more
  • Boston, Massachusetts
  • +2 more
Aug 14, 2023